publication venue for
- Efficacy of leflunomide in the treatment of vasculitis 2021
- Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry 2020
- CANADIAN OBSERVATIONAL STUDY ASSESSING THE EFFECTIVENESS OF ADALIMUMAB VS. NON-BIOLOGIC DMARDS IN ANKYLOSING SPONDYLITIS (COMPLETE-AS): 12-MONTH DATA 2018
- CANADIAN OBSERVATIONAL STUDY ASSESSING THE EFFECTIVENESS OF ADALIMUMAB VS. NON-BIOLOGIC DMARDS IN PSORIATIC ARTHRITIS (COMPLETE-PsA): 12-MONTH DATA 2018
- DIAGNOSTIC ASCERTAINMENT OF AXIAL SPONDYLOARTHRITIS IN PATIENTS PRESENTING WITH UNDIAGNOSED BACK PAIN: WHAT IS THE IMPACT OF MRI IN RHEUMATOLOGICAL PRACTICE? 2018
- VALIDATION OF A WEB-BASED CALIBRATION MODULE FOR THE SPARCC MRI SIJ INFLAMMATION SCORE BASED ON PRINCIPLES OF ARTIFICIAL INTELLIGENCE 2018
- Quantification of proteoglycan 4 (PRG4)/lubricin in normal and Sjogren syndrome human tears 2018
- Serum coagulation markers and cerebral MRI in lupus patients with antiphospholipid antibodies and cognitive dysfunction 2015
- ABNORMALITIES OF REPOLARIZATION IN ECG IN PATIENTS WITH CHURG-STRAUSS SYNDROME 2011
- AUTONOMIC NERVOUS SYSTEM DYSFUNCTION IN PATIENTS WITH CHURG-STRAUSS SYNDROME 2011
- INFLUENCE OF DELAYED DIAGNOSIS ON THE COURSE OF CHURG-STRAUSS SYNDROME 2011
- A STUDY OF SCLERODERMA IN SOUTH OF BRAZIL: CUTANEOUS MANIFESTATIONS AND CLINICAL-LABORATORIAL MARKERS ASSOCIATION 2010
- Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.. 41:2249-2256. 2023
- Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative. 41:118-125. 2023
- Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry. 40:720-726. 2022
- Counselling patients for return to work on immunosuppression: practices of Canadian specialists during the COVID-19 pandemic. 39:874-878. 2021
- Efficacy of leflunomide in the treatment of vasculitis. 39:S114-S118. 2021
- Identifying pain susceptibility phenotypes in knee osteoarthritis.. 37 Suppl 120:96-99. 2019
- Ixekizumab improves patient-reported outcomes in patients with active psoriatic arthritis and inadequate response to tumour necrosis factor inhibitors: SPIRIT-P2 results to 52 weeks.. 37:566-574. 2019
- Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma. 37:S40-S44. 2019
- Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma.. 37 Suppl 117:40-44. 2019
- The association of sociodemographic and disease variables with hand function: a Scleroderma Patient-centered Intervention Network cohort study.. 36 Suppl 113:88-94. 2018
- IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss). 35:S98-S101. 2017
- IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).. 35 Suppl 103:98-101. 2017
- Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis. 35:S56-S60. 2017
- Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.. 35 Suppl 106:56-60. 2017
- Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.. 35:799-803. 2017
- Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.. 34 Suppl 100:92-99. 2016
- Neutrophil-related and serum biomarkers in granulomatosis with polyangiitis support extracellular traps mechanism of the disease. 34:S98-S104. 2016
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. 33:S77-S83. 2015
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts.. 33:S-77-83. 2015
- Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.. 33:S131-S135. 2015
- Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.. 33:537-544. 2015
- Reply to: Methotrexate and not much harm to the lungs. 32:S11-S11. 2014
- ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center.. 32:S41-S47. 2014
- Reply to: methotrexate and not much harm to the lungs by H. Yazici.. 32:S-11. 2014
- Achieving remission in clinical practice: lessons from clinical trial data.. 31:621-632. 2013
- The excess burden of rheumatoid arthritis in Ontario, Canada.. 31:18-24. 2013
- Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis.. 29:624-632. 2011
- Quantitative, small bore, 1 Tesla, magnetic resonance imaging of the hands of patients with rheumatoid arthritis.. 26:860-865. 2008
- Resource utilization and the cost of rheumatoid arthritis in Brazil.. 26:24-31. 2008
- The patient-rated wrist evaluation (PRWE): cross-cultural adaptation into German and evaluation of its psychometric properties.. 26:1047-1058. 2008
- Computerized administration of health-related quality of life instruments compared to interviewer administration may reduce sample size requirements in clinical research: a pilot randomized controlled trial among rheumatology patients.. 25:577-583. 2007
- Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis.. 25:754-757. 2007
- The Gap Study (GapS) interview--developing a process to determine the meaning and determinants of quality of life in children with arthritis and rheumatic disease.. 25:486-493. 2007
- Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. 18:S79-S86. 2000
- Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis. 18. 2000
- Intermittent therapy with etidronate and calcium helps prevent osteoporosis secondary to steroids. 16:117-118. 1998
- EPM-ROM Scale: an evaluative instrument to be used in rheumatoid arthritis trials.. 8:491-494. 1990
- Frequency of administration of short half-life nonsteroidal anti-inflammatory analgesics (NSAID's): studies with ibuprofen.. 4:91-93. 1986
- The M.D.R. index of function in rheumatoid arthritis.. 3:297-302. 1985
- Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome. 29:S23-S34.